Boardroom Alpha
Boardroom Alpha
FRPT · Current Report (Form 8-K) · Filed June 11, 2026

Freshpet Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 11, 2026
Period
Jun 10, 2026
Ticker
FRPT
Accession
0000929638-26-002206
Boardroom Alpha · Filing insights

All board nominees elected; independent auditor ratified; executive compensation advisory approved at Freshpet's 2026 annual meeting.

About Freshpet Inc
Market cap
$3.4B
1Y TSR
+12.8%
3Y TSR
−3.1%
Board grade
C+
Sector
Consumer Defensive
CEO
William B Cyr
Last annual meeting: Jun 10, 2026 · View full Freshpet Inc profile →


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  June 10, 2026

Freshpet, Inc.
(Exact name of registrant as specified in its charter)

Delaware
 
001-36729
 
20-1884894
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

1450 US-206
Bedminster, New Jersey
 
07921
(Address of principal executive offices)
 
(Zip code)

Registrant's telephone number, including area code:  201 520-4000


(Former Name or Former Address, if Changed Since Last Report)
___________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
FRPT
The NASDAQ Global Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐





Item 5.07.
Submission of Matters to a Vote of Security Holders.

At the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Freshpet, Inc. (the “Company”) held on June 10, 2026, the Company’s stockholders considered three proposals, each of which is described in more detail in the Company’s definitive Proxy Statement filed with the Securities and Exchange Commission on April 27, 2026. The final results for each proposal presented at the Annual Meeting are set forth below:

(1) Election of Directors. All nominees were elected to serve on the Board of Directors pursuant to the following votes:

DIRECTOR
FOR
 
AGAINST
 
ABSTAIN
Olu Beck
42,454,032
 
73,236
 
51,235
David B. Biegger
42,397,351
 
87,288
 
93,864
Daryl G. Brewster
41,902,595
 
624,884
 
51,024
William B. Cyr
42,386,993
 
140,271
 
51,239
Walter N. George III
42,195,460
 
289,450
 
93,593
Jacki S. Kelley
42,397,616
 
129,971
 
50,916
Lauri Kien Kotcher
42,064,536
 
338,968
 
174,999
Timothy R. McLevish
42,377,806
 
104,459
 
96,238
Leta D. Priest
41,918,540
 
566,406
 
93,557
Joseph E. Scalzo
42,108,117
 
376,793
 
93,593
Craig D. Steeneck
42,281,854
 
202,954
 
93,695
David J. West
42,373,592
 
111,317
 
93,594

There were 2,475,309 broker non-votes with respect to this matter.

(2) Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2026 was ratified with the following votes:

FOR
AGAINST
ABSTAIN
44,890,659
115,995
47,158

There were no broker non-votes with respect to this matter.

(3) Non-Binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers. The executive compensation of the Company’s named executive officers was approved with the following non-binding advisory votes:

FOR
AGAINST
ABSTAIN
40,844,496
1,682,726
51,281

There were 2,475,309 broker non-votes with respect to this matter.


SIGNATURE
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Date: June 11, 2026

 
FRESHPET, INC.
     
 
By:
/s/ Lisa Alexander
 
Name:
Lisa Alexander
 
Title:
General Counsel and Corporate Secretary
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Freshpet Inc (FRPT)

Reference

Frequently asked questions

When did Freshpet Inc file this 8-K?
Freshpet Inc (FRPT) filed this Current Report (Form 8-K) with the SEC on June 11, 2026. The accession number assigned by EDGAR is 0000929638-26-002206.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
All board nominees elected; independent auditor ratified; executive compensation advisory approved at Freshpet's 2026 annual meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Freshpet Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Freshpet Inc has filed under CIK 1611647, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer